Posters

      Optimization of Histological Processing of Murine Lung Tissue

      Seow, E.; Phillips, B.; Veljkovic, E.; Vanscheeuwijck, P.
      Conference date
      Sep 20, 2013
      Conference name
      NSH 2013
      Link to more information
      Link to more information
      Topic
      Summary

      In a previous murine study, signs of lung tissue shrinkage and alveolar collapse were consistently found in tissues stored in 70% ethanol for more than 3 months. It was hypothesized that extended storage in 70% ethanol could be the cause of these adverse observations. This study was carried out to: i) identify the cause(s) of the artifacts observed, and ii) investigate the impact of the duration of storage in 70% ethanol prior to processing on the tissue quality. Since 4% formaldehyde is the most commonly used fixative, quality of tissue with fixation in 4% formaldehyde was also evaluated and compared with 70% ethanol. A total of 20 female C57BL/6 mice bred under specific pathogen-free conditions were used. At necropsy, whole lungs were instilled with primary fixative for 48 hours. After this, the left lung lobes were stored in 70% ethanol for the following periods, 1, 3, 6, 9 and 12 weeks and used for the evaluation of the impact of this storage on the tissue quality. The right lung lobes were used to assess the quality of tissue after storing in 4% formaldehyde for the same periods of time. Tissue processing and embedding in paraffin wax were performed according to standard protocols for both left and right lung lobes. Step-serial sections (4-µm thin) were then made from the paraffin embedded right and left lung lobes at intervals of 150 µm, stained with Haematoxylin-Eosin and evaluated by the pathologist. Artifacts were observed in almost all lung tissue samples regardless of the length of the storage in either 70% ethanol or 4% formaldehyde. Tissue alterations observed in this study were comparable to the observation noted in the previous study. As physical compression during embedding was suspected to be the cause of the tissue artifacts, 9 left lung lobes were used to investigate the effect of lung tissue compression. Three left lung lobes were compressed and the remaining lung lobes embedded without any compression. Step-serial sections (4-µm thin) were made at intervals of 150 µm, stained with Haematoxylin-Eosin and evaluated by the pathologist. The use of physical compression of lung tissue during the embedding process was confirmed to result in the observed tissue alterations. 

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.